A groundbreaking new longitudinal study, published April 1, 2026, in Neurology Open Access, an official journal of the American Academy…
Read More
JAMA Study Links Moderate Caffeine Intake to Lower Dementia Risk, Providing a Potent Nudge for Adenosine Pathway Drug Hunters
A comprehensive prospective cohort study, published online February 9, 2026, in the prestigious journal JAMA, has unveiled compelling evidence suggesting…
Read More
JAMA study finds moderate caffeine intake tracks with lower dementia risk, provides adenosine-pathway nudge for drug hunters
A landmark prospective cohort study, published online on February 9, 2026, in the esteemed journal JAMA, has unveiled a compelling…
Read More
